A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers
CompletedOBSERVATIONAL
Enrollment
2,500
Participants
Timeline
Start Date
August 31, 2014
Primary Completion Date
December 31, 2020
Study Completion Date
February 28, 2021
Conditions
CirrhosisChronic Liver Diseases
Trial Locations (2)
M5G 2C4
Toronto General Hospital, Toronto
M5T 2S8
Toronto Western Hospital, Toronto
All Listed Sponsors
lead
Wako Life Sciences
INDUSTRY
NCT02272504 - A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers | Biotech Hunter | Biotech Hunter